| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 593.99M | 522.31M | 487.67M | 356.85M | 181.12M |
| Gross Profit | 153.53M | 142.50M | 131.31M | 100.95M | 63.98M |
| EBITDA | -13.74M | 33.78M | -4.20M | -33.65M | -1.96M |
| Net Income | -50.75M | -4.34M | -39.31M | -70.85M | -35.04M |
Balance Sheet | |||||
| Total Assets | 349.06M | 246.21M | 233.40M | 274.74M | 246.22M |
| Cash, Cash Equivalents and Short-Term Investments | 47.95M | 47.98M | 30.26M | 25.28M | 14.87M |
| Total Debt | 149.83M | 74.61M | 72.53M | 69.88M | 55.43M |
| Total Liabilities | 246.28M | 100.70M | 99.73M | 112.71M | 94.21M |
| Stockholders Equity | 87.61M | 143.27M | 131.56M | 156.35M | 147.21M |
Cash Flow | |||||
| Free Cash Flow | 13.43M | 25.80M | 14.58M | -4.56M | -13.54M |
| Operating Cash Flow | 23.87M | 35.55M | 20.66M | 4.50M | -2.83M |
| Investing Cash Flow | -22.29M | -11.01M | -5.72M | -8.59M | -28.49M |
| Financing Cash Flow | 202.00K | -7.72M | -9.26M | 15.17M | 37.81M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
53 Neutral | C$317.32M | -1.53 | -43.99% | ― | -11.16% | -29.56% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
47 Neutral | C$547.01M | -0.54 | -60.19% | ― | -0.67% | 58.98% | |
47 Neutral | C$149.49M | -1.62 | ― | ― | 3.17% | -24.07% | |
43 Neutral | C$267.03M | -5.20 | -6.77% | ― | 11.18% | 70.04% | |
42 Neutral | C$76.46M | -0.64 | -83.55% | ― | 2.19% | -91.41% | |
40 Neutral | C$18.10M | -0.04 | ― | ― | 0.63% | -31.86% |
High Tide reported record fourth-quarter revenue of $164 million and its highest-ever adjusted EBITDA for fiscal 2025, while remaining free cash flow positive for the year and achieving a revenue run-rate above $650 million. The company delivered 4.1% same-store sales growth for the fiscal year and 5.5% in the fourth quarter, opened 27 new Canna Cabana locations to reach 218 stores nationally, and expanded brick-and-mortar EBITDA margins to a record 9.4% in Q4, reinforcing its ambition for 12% margins over the longer term. High Tide continues to lead the Canadian cannabis retail market with a 12% share in the provinces where it operates, supported by rapid growth in its loyalty base to more than 2.5 million Cabana Club members and over 151,000 ELITE members, which management describes as key competitive assets. Internationally, the closing of the majority acquisition of Germany’s Remexian Pharma GmbH has established High Tide as a major importer and distributor of medical cannabis in that market; despite temporary supply-chain disruptions, the German business is regaining momentum, and the company is exploring additional partnerships in the U.K. to extend Remexian’s footprint and further diversify its revenue base beyond Canada.
The most recent analyst rating on (TSE:HITI) stock is a Hold with a C$4.00 price target. To see the full list of analyst forecasts on High Tide stock, see the TSE:HITI Stock Forecast page.
High Tide Inc. will report its fourth fiscal quarter and full-year 2025 financial and operational results after markets close on January 29, 2026, with the disclosures to be made available on SEDAR+, EDGAR and the company’s website. Management, including founder and CEO Raj Grover and CFO Mayank Mahajan, will host a webcast on January 30, 2026, to review the results and outline plans for 2026, offering investors and analysts an opportunity to gauge the company’s strategic direction and performance in the context of its expanding retail footprint and international medical cannabis distribution operations.
The most recent analyst rating on (TSE:HITI) stock is a Hold with a C$4.50 price target. To see the full list of analyst forecasts on High Tide stock, see the TSE:HITI Stock Forecast page.
High Tide Inc. marked 2025 as a transformational year, evolving from a domestic market leader into a global cannabis retailer while maintaining positive free cash flow and scaling its Canna Cabana footprint to 218 stores. The company entered the German medical cannabis market via a majority stake in Remexian Pharma, becoming one of that country’s largest importers and distributors of medical cannabis, and reported an annualized revenue run rate of $600 million and adjusted EBITDA run rate above $42 million, driven by robust same-store sales growth and strong sales per square foot. With more than 2.4 million Cabana Club members, including 139,000 ELITE members, and a 12% retail market share across the five Canadian provinces where it operates, High Tide reinforced its leadership in cannabis retail while expanding its white-label Queen of Bud product portfolio and earning repeated recognition on national growth and exchange rankings, underscoring its strengthening operational and financial position ahead of further international and potential U.S. expansion.
The most recent analyst rating on (TSE:HITI) stock is a Hold with a C$4.50 price target. To see the full list of analyst forecasts on High Tide stock, see the TSE:HITI Stock Forecast page.
High Tide has welcomed a historic U.S. Executive Order that advances the rescheduling of cannabis and paves the way for a federal pilot program under which certain Medicare beneficiaries could receive CBD treatments at no cost, a move the company says underscores growing bipartisan support for more pragmatic cannabis and CBD policies. In response, High Tide is assessing a licensing-based entry for its flagship Canna Cabana retail brand into the U.S., while NuLeaf Naturals and FAB CBD are developing product lines tailored to potential Medicare Advantage supplemental benefits, leveraging their CGMP-certified, THC-free and broad-spectrum offerings to position for leadership in a Medicare-aligned CBD category. The company also disclosed that it has reengaged IR Agency to enhance investor relations and market communications, aiming to better connect with existing and prospective shareholders as it pursues long-term growth across both federally compliant CBD wellness and regulated cannabis markets.
The most recent analyst rating on (TSE:HITI) stock is a Hold with a C$4.50 price target. To see the full list of analyst forecasts on High Tide stock, see the TSE:HITI Stock Forecast page.
High Tide Inc. is expanding its Canna Cabana retail chain by opening three new locations in Calgary, London, and Brampton, bringing its total to 218 stores across Canada. This expansion highlights the company’s strategic growth in high-demand markets and its commitment to reaching its annual goals, reinforcing its position as a dominant player in the cannabis retail industry.
The most recent analyst rating on (TSE:HITI) stock is a Hold with a C$4.50 price target. To see the full list of analyst forecasts on High Tide stock, see the TSE:HITI Stock Forecast page.
High Tide Inc. has opened its first international Canna Cabana store in Berlin, marking its entry into the European market. This move represents a strategic step in expanding its retail presence in Europe, particularly in Germany, which is Europe’s largest cannabis market. The Berlin store is part of High Tide’s broader strategy to capitalize on the growing demand for cannabis accessories and consumer lifestyle goods, positioning the company for future growth as Germany moves towards broader cannabis liberalization.
The most recent analyst rating on (TSE:HITI) stock is a Hold with a C$4.50 price target. To see the full list of analyst forecasts on High Tide stock, see the TSE:HITI Stock Forecast page.
High Tide Inc. announced the opening of four new Canna Cabana locations in Alberta and Ontario, increasing its total store count to 215 across Canada. This expansion reflects the company’s strategic growth in key markets, enhancing its brand presence and market share while also granting stock options to employees to align with its growth objectives.
The most recent analyst rating on (TSE:HITI) stock is a Hold with a C$4.50 price target. To see the full list of analyst forecasts on High Tide stock, see the TSE:HITI Stock Forecast page.